2EMA. Guideline: Guideline on the Investigation of Bioequivalence [s]. 2010.
3FDA. Draft Guidance for Industry: Bioavailability and Bioequiva- lence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System[ S]. 2015.
4FDA. Guidance for Industry: Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System[ S]. 2000.
5WHO. Guidance: General notes on Biopharmaceutics Classifica- tion System (BCS) -based biowaiver applications[ S ]. 2014.
6WHO Technical Report Series. Annex 7 : Muhisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability[ S]. 2006.